Загрузка...
Progenitor-derived human endothelial cells evade alloimmunity by CRISPR/Cas9-mediated complete ablation of MHC expression
Tissue engineering may address organ shortages currently limiting clinical transplantation. Off-the-shelf engineered vascularized organs will likely use allogeneic endothelial cells (ECs) to construct microvessels required for graft perfusion. Vasculogenic ECs can be differentiated from committed pr...
Сохранить в:
| Опубликовано в: : | JCI Insight |
|---|---|
| Главные авторы: | , , , , , , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
American Society for Clinical Investigation
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6824302/ https://ncbi.nlm.nih.gov/pubmed/31527312 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.129739 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|